Breaking News Instant updates and real-time market news.

INCY

Incyte

$64.02

-19.05 (-22.93%)

07:57
04/09/18
04/09
07:57
04/09/18
07:57

Incyte price target lowered to $76 from $142 at Morgan Stanley

Morgan Stanley analyst Thomas Smith lowered his price target on Incyte to $76 after removing epacadostat from his model following the announcement that the ECHO-301 trial failed to show benefit over PD-1 monotherapy in melanoma. However, Smith believes Incyte shares already reflected a significant amount of investor skepticism heading into the ECHO-301 data and he views the company as having one of the deepest pipelines in SMID-cap biotech, supported by the Jakafi base business in myelofibrosis, Iclusig royalties in Europe and royalties from baricitinib. Smith keeps an Overweight rating on Incyte shares.

  • 23

    Apr

  • 12

    Jun

INCY Incyte
$64.02

-19.05 (-22.93%)

04/09/18
OPCO
04/09/18
NO CHANGE
Target $65
OPCO
Perform
Incyte price target lowered to $65 from $110 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Incyte (INCY) to $65 from $110 following the update on the termination of ECHO-301 after epacadostat failed to show a PFS or OS benefit when combined with Merck's (MRK) Keytruda versus Keytruda alone. While the company plans to conduct subgroup analyses of ECHO-301 looking at various biomarkers such as PD-L1 expression and tumor mutational burden which may provide additional insights, the analyst sees no reason at this time to continue development of epacadostat as he considers it highly unlikely to demonstrate efficacy in other tumor types and/or combinations. Olson reiterates a Perform rating on Incyte's shares.
04/09/18
NOMU
04/09/18
NO CHANGE
Target $102
NOMU
Buy
Incyte price target lowered to $102 from $139 at Nomura Instinet
Nomura Instinet analyst Christopher Marai on Friday lowered his price target for Incyte to $102 after the Phase ECHO-301 trial of epacadostat and pembrolizumab in advanced metastatic melanoma was stopped. The analyst keeps a Buy rating on the shares. He tells investors to focus on the company's TKI pipeline.
04/09/18
RHCO
04/09/18
DOWNGRADE
Target $5
RHCO
Hold
NewLink Genetics downgraded to Hold at SunTrust on Incyte trial failure
As reported late last week, SunTrust analyst Peter Lawson downgraded NewLink Genetics (NLNK) to Hold from Buy and lowered his price target to $5 from $19. Lawson cites the announcement of negative results from the Phase 3 ECHO-301 of epacadostat + Keytruda in melanoma by Incyte (INCY), saying the data also implies a "significant negative read through for NewLink's IDO agent, indoximod". Lawson adds that the results have led him to remove melanoma from his NewLink model and also reduce the probability of success in pancreatic cancer, lowering the probability of adjusted peak sales from $415M to just $11M.
04/09/18
HCWC
04/09/18
NO CHANGE
Target $125
HCWC
Buy
Nektar data 'more robust' than Incyte's, says H.C. Wainwright
The failure of Incyte (INCY) and Merck's (MRK) Phase 3 study negatively impacted trading in Nektar Therapeutics (NKTR) shares on Friday, H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note titled "Collateral Damage Not Surprising; Expecting ASCO-18 to Validate the Master T Cell Regulator Hypothesis." At this year's American Society of Clinical Oncology meeting, the analyst expects Nektar and partner Bristol-Myers Squibb (BMY) to unveil data from at least 40 advanced melanoma patients "supported by in-depth biomarker characterization to comprehensively ascertain the rationale of combining NKTR-214 with Opdivo." The rationale for combining NKTR-214 with Opdivo is "more robust" than epacadostat plus Keytruda, the analyst contends. Further, he believes data generated by the NKTR-214 plus Opdivo combination is "unambiguous." Chattopadhyay reiterates a Buy rating on Nektar shares with a $125 price target.

TODAY'S FREE FLY STORIES

OPTN

Optinose

$12.86

-6.64 (-34.05%)

15:28
08/14/18
08/14
15:28
08/14/18
15:28
Recommendations
Optinose analyst commentary  »

Piper not worried by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BOOT

Boot Barn

$27.93

1.04 (3.87%)

15:20
08/14/18
08/14
15:20
08/14/18
15:20
Options
Sweep call buyers in Boot Barn as shares lift on heavy volume »

Sweep call buyers in Boot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CREE

Cree

$49.94

-0.34 (-0.68%)

15:19
08/14/18
08/14
15:19
08/14/18
15:19
Options
Cree options imply 15.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/14/18
08/14
15:17
08/14/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/14/18
08/14
15:16
08/14/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSBR

Champions Oncology

$7.80

0.315 (4.21%)

15:12
08/14/18
08/14
15:12
08/14/18
15:12
Conference/Events
Champions Oncology management to meet with Craig-Hallum »

.Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

GLF

GulfMark Offshore

$38.18

0.48 (1.27%)

15:10
08/14/18
08/14
15:10
08/14/18
15:10
Hot Stocks
Breaking Hot Stocks news story on GulfMark Offshore »

GulfMark Offshore Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.02

1.89 (0.67%)

15:06
08/14/18
08/14
15:06
08/14/18
15:06
Technical Analysis
Technical Take: SPDR S&P 500 ETF near session highs in final hour of trading »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.02

1.89 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$67.01

1.06 (1.61%)

15:04
08/14/18
08/14
15:04
08/14/18
15:04
Options
Agilent options imply 9.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 19

    Aug

  • 21

    Aug

CLF

Cleveland-Cliffs

$9.97

-0.235 (-2.30%)

15:00
08/14/18
08/14
15:00
08/14/18
15:00
Options
15K Cleveland Cliffs Aug - Oct 8 call spreads bought for 17c »

15K Cleveland Cliffs Aug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

15:00
08/14/18
08/14
15:00
08/14/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

WMT

Walmart

$90.90

1.24 (1.38%)

14:59
08/14/18
08/14
14:59
08/14/18
14:59
Hot Stocks
Walmart opens distribution center in Mobile, Alabama »

Walmart commemorated the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

SPR

Spirit AeroSystems

$86.53

-0.23 (-0.27%)

14:57
08/14/18
08/14
14:57
08/14/18
14:57
Hot Stocks
Spirit AeroSystems VP Michelle Lohmeier sells almost $300K in company stock »

Spirit AeroSystems VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$193.85

2.4 (1.25%)

, UXIN

Uxin

$5.54

-0.61 (-9.92%)

14:57
08/14/18
08/14
14:57
08/14/18
14:57
Hot Stocks
Tiger Global adds Spotify and Adobe, exits United Continental »

Chase Coleman's…

SPOT

Spotify

$193.85

2.4 (1.25%)

UXIN

Uxin

$5.54

-0.61 (-9.92%)

COUP

Coupa Software

$67.20

1.66 (2.53%)

ADBE

Adobe

$255.81

2.23 (0.88%)

GDS

GDS Holdings

$30.05

-2.58 (-7.91%)

EHIC

eHi Car Services

$12.90

0.05 (0.39%)

ARCC

Ares Capital

$17.37

0.015 (0.09%)

UAL

United Continental

$81.84

0.58 (0.71%)

TWTR

Twitter

$33.04

0.24 (0.73%)

FB

Facebook

$180.91

0.83 (0.46%)

NOW

ServiceNow

$184.66

-0.38 (-0.21%)

MLI

Mueller Industries

$31.95

0.18 (0.57%)

RUN

Sunrun

$12.99

-0.22 (-1.67%)

RDFN

Redfin

$18.04

-0.5 (-2.70%)

JD

JD.com

$33.55

-1.51 (-4.31%)

TDG

TransDigm

$355.86

-0.2 (-0.06%)

MSFT

Microsoft

$109.51

1.27 (1.17%)

AMZN

Amazon.com

$1,915.47

19.96 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 04

    Sep

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

DENN

Denny's

$14.66

0.12 (0.83%)

14:53
08/14/18
08/14
14:53
08/14/18
14:53
Conference/Events
Denny's participates in a conference call with Stephens »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 16

    Aug

  • 06

    Nov

WPM

Wheaton Precious Metals

$19.94

-0.1 (-0.50%)

14:49
08/14/18
08/14
14:49
08/14/18
14:49
Options
Wheaton Precious Metals options imply 5.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

DWSN

Dawson Geophysical

$5.90

0.04 (0.68%)

14:48
08/14/18
08/14
14:48
08/14/18
14:48
Hot Stocks
Dawson Geophysical director William Barrett buys over $100K in stock »

Dawson Geophysical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$180.92

0.84 (0.47%)

, GOOG

Alphabet

$1,242.00

6.9 (0.56%)

14:48
08/14/18
08/14
14:48
08/14/18
14:48
Conference/Events
William Blair digital media analyst to hold a meeting »

Analysts, along with the…

FB

Facebook

$180.92

0.84 (0.47%)

GOOG

Alphabet

$1,242.00

6.9 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

14:46
08/14/18
08/14
14:46
08/14/18
14:46
Conference/Events
William Blair SaaS analyst to hold a group luncheon »

Software as a Service…

GLF

GulfMark Offshore

$38.18

0.48 (1.27%)

14:45
08/14/18
08/14
14:45
08/14/18
14:45
Hot Stocks
Breaking Hot Stocks news story on GulfMark Offshore »

GulfMark Offshore Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$30.38

0.63 (2.12%)

, BABA

Alibaba

$171.94

-5.715 (-3.22%)

14:44
08/14/18
08/14
14:44
08/14/18
14:44
Hot Stocks
Kroger announces pilot for sales in China via Alibaba's Tmall platform »

Kroger (KR) announced a…

KR

Kroger

$30.38

0.63 (2.12%)

BABA

Alibaba

$171.94

-5.715 (-3.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 10

    Sep

14:43
08/14/18
08/14
14:43
08/14/18
14:43
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail/Hardlines Analyst…

TWTR

Twitter

$33.03

0.23 (0.70%)

14:43
08/14/18
08/14
14:43
08/14/18
14:43
Hot Stocks
Twitter suspends accounts for trying to evade account suspension »

Twitter's Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

PLNT

Planet Fitness

$51.74

2.75 (5.61%)

14:40
08/14/18
08/14
14:40
08/14/18
14:40
Options
Bullish flow in Planet Fitness as shares rebound »

Bullish flow in Planet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$87.59

0.56 (0.64%)

14:30
08/14/18
08/14
14:30
08/14/18
14:30
Options
Bullish option play opened in Paypal »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.